Literature DB >> 11557354

2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands.

S Selleri1, F Bruni, C Costagli, A Costanzo, G Guerrini, G Ciciani, B Costa, C Martini.   

Abstract

A new class of N,N-diethyl-(2-arylpyrazolo[1,5-a]pyrimidin-3-yl)acetamides (3f-y), as azaisosters of Alpidem, was prepared following a novel synthetic method and their affinities for both the peripheral (PBR) and the central (CBR) benzodiazepine receptors were evaluated. Binding assays were carried out using both [3H]PK 11195 and [3H]Ro 5-4864 as radioligands for PBR, whereas [3H]Ro 15-1788 was used for CBR, in rat kidney and rat cortex, respectively. The tested compounds exhibited a broad range of binding affinities from as low as 0.76 nM to inactivity and most of them proved to be high selective ligands for PBR. The preliminary SAR studies suggested some of the structural features required for high affinity and selectivity; particularly the substituents on the pyrimidine moiety seemed to play an important role in PBR versus CBR selectivity. A subset of the highest affinity compounds was also tested for their ability to stimulate steroid biosynthesis in C6 glioma rat cells and some of these were found to increase pregnenolone formation with potency similar to Ro 5-4864 and PK 11195.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557354     DOI: 10.1016/s0968-0896(01)00192-4

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

1.  Synthesis of some new pyrazolo[1,5-a]pyrimidine, pyrazolo[5,1-c]triazine, 1,3,4-thiadiazole and pyridine derivatives containing 1,2,3-triazole moiety.

Authors:  Nadia A Abdelriheem; Yasser H Zaki; Abdou O Abdelhamid
Journal:  Chem Cent J       Date:  2017-06-12       Impact factor: 4.215

2.  New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO.

Authors:  Jun Li; Michael L Schulte; Michael L Nickels; H Charles Manning
Journal:  Bioorg Med Chem Lett       Date:  2016-06-16       Impact factor: 2.823

3.  The first dipeptide ligand of translocator protein: Design and anxiolytic activity.

Authors:  T A Gudasheva; O A Deeva; G V Mokrov; S A Yarkov; M A Yarkova; S B Seredenin
Journal:  Dokl Biochem Biophys       Date:  2015-10-31       Impact factor: 0.788

4.  Microwave-assisted Organic Synthesis of a High-affinity Pyrazolo-pyrimidinyl TSPO Ligand.

Authors:  Dewei Tang; Jason R Buck; Matthew R Hight; H Charles Manning
Journal:  Tetrahedron Lett       Date:  2010-09-01       Impact factor: 2.415

5.  Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging.

Authors:  Dewei Tang; Eliot T McKinley; Matthew R Hight; Md Imam Uddin; Joel M Harp; Allie Fu; Michael L Nickels; Jason R Buck; H Charles Manning
Journal:  J Med Chem       Date:  2013-04-03       Impact factor: 7.446

6.  Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

Authors:  Christopher J Endres; Martin G Pomper; Michelle James; Ovsev Uzuner; Dima A Hammoud; Crystal C Watkins; Aaron Reynolds; John Hilton; Robert F Dannals; Michael Kassiou
Journal:  J Nucl Med       Date:  2009-07-17       Impact factor: 10.057

7.  Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.

Authors:  Yong-Sok Lee; Fabrice G Siméon; Emmanuelle Briard; Victor W Pike
Journal:  ACS Chem Neurosci       Date:  2012-02-14       Impact factor: 4.418

8.  Serotonin transporter (SERT) and translocator protein (TSPO) expression in the obese ob/ob mouse.

Authors:  Gino Giannaccini; Laura Betti; Lionella Palego; Andrea Pirone; Lara Schmid; Mario Lanza; Laura Fabbrini; Caterina Pelosini; Margherita Maffei; Ferruccio Santini; Aldo Pinchera; Antonio Lucacchini
Journal:  BMC Neurosci       Date:  2011-02-07       Impact factor: 3.288

9.  [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis.

Authors:  Janine Doorduin; Hans C Klein; Rudi A Dierckx; Michelle James; Michael Kassiou; Erik F J de Vries
Journal:  Mol Imaging Biol       Date:  2009-03-28       Impact factor: 3.488

Review 10.  TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?

Authors:  Bérenger Largeau; Anne-Claire Dupont; Denis Guilloteau; Maria-João Santiago-Ribeiro; Nicolas Arlicot
Journal:  Contrast Media Mol Imaging       Date:  2017-09-25       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.